Angelique Egberts

Angelique Egberts is a Researcher in the Department of Internal Medicine at Erasmus MC, focusing on pharmacological and clinical aspects of delirium and medication safety in older adults. Her work bridges clinical practice and pharmaceutical research, contributing to safer prescribing in geriatric populations.

Her research interests center on delirium, anticholinergic drug burden, medication errors, and adverse drug reactions, particularly in hospitalized elderly patients. She investigates the impact of drugs like lorazepam and antipsychotics on delirium outcomes and long-term mortality. Her work also explores potential biomarkers such as neopterin and tryptophan to understand delirium pathophysiology across different patient groups.

The recent publications highlight a consistent focus on drug-related causes and consequences of delirium, with strong emphasis on systematic reviews and real-world data analysis. Her work frequently appears in high-impact journals in geriatrics and clinical pharmacology, demonstrating a commitment to evidence-based medicine and patient safety.

Scientific Awards:

• No scientific awards mentioned in the provided text.

Advising and Grants: There is no mention of students, advisees, or grant funding in the provided information. However, her publication record suggests active collaboration with researchers such as F.U.S. Mattace-Raso, C. Oudshoorn, and B. Ziere, indicating participation in research teams and likely involvement in funded projects.

Labs and Teams: While specific lab affiliations are not stated, her work is embedded within the Internal Medicine department at Erasmus MC, likely involving multidisciplinary teams focused on geriatric pharmacology, clinical pharmacology, and patient safety research.